Moreover, ZFPM2 expression levels were negatively correlated with glioma grades, suggesting that ZFPM2 expression can be a potentially useful indicator of disease severity for gliomas, as well as a significant factor in glioma pathogenesis, in which case ZFPM2 could provide a valuable target for glioma therapeutics. Here, ZFPM2 is linked to glioma.